Abstract
We evaluated a neonate with severe jaundice but a negative family history. Spherocytes were present and suspected hereditary spherocytosis was confirmed by osmotic fragility and eosin-5-maleimide erythrocyte staining. We found he was a compound heterozygote for two pathogenic mutations in the gene encoding α-spectrin: a previously reported αLEPRA inherited from his asymptomatic mother, and a novel α-spectrin mutation in intron 45 +1 disrupting the consensus splice site, from his asymptomatic father.
References
1.
Gallagher PG: Disorders of red cell volume regulation. Curr Opin Hematol 2013;20:201-207.
2.
Christensen RD, Henry E: Hereditary spherocytosis in neonates with hyperbilirubinemia. Pediatrics 2010;125:120-125.
3.
Christensen RD, Lambert DK, Henry E, Eggert LD, Yaish HM, Reading NS, Prchal JT: Unexplained extreme hyperbilirubinemia among neonates in a multihospital healthcare system. Blood Cells Mol Dis 2013;50:105-109.
4.
Wichterle H, Hanspal M, Palek J, Jarolim P: Combination of two mutant α-spectrin alleles underlies a severe spherocytic hemolytic anemia. J Clin Invest 1996;98:2300-2307.
5.
Saada V, Cynober T, Brossard Y, Schischmanoff PO, Sender A, Cohen H, Delaunay J, Tchernia G: Incidence of hereditary spherocytosis in a population of jaundiced neonates. Pediatr Hematol Oncol 2006;23:387-397.
6.
Parpart AK, Lorenz PB: The osmotic resistance (fragility) of human red cells. J Clin Invest 1947;26:636-640.
7.
King MJ, Telfer P, MacKinnon H, Langabeer L, McMahon C, Darbyshire P, Dhermy D: Using the eosin-5-maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis. Cytometry B Clin Cytom 2008;74:244-250.
8.
Yaish HM, Nussenzveig RH, Agarwal AM, Siddiqui AH, Christensen RD: A previously unknown mutation in the pyruvate kinase gene (PKLR) identified from a neonate with severe jaundice. Neonatology 2014;106:140-142.
9.
Christensen RD, Nussenzveig RH, Yaish HM, Henry E, Eggert LD, Agarwal AM: Causes of hemolysis in neonates with extreme hyperbilirubinemia. J Perinatol 2014;34:616-619.
10.
Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM: Clinical report from the pilot USA Kernicterus Registry (1992-2004). J Perinatol 2009;29(suppl 1):S25-S45.
11.
King MJ, Zanella A: Hereditary red cell membrane disorders and laboratory diagnostic testing. Int J Lab Hematol 2013;35:237-243.
12.
Yaish HM, Christensen RD, Agarwal A: A neonate with Coombs-negative hemolytic jaundice with spherocytes but normal erythrocyte indices: a rare case of autosomal-recessive hereditary spherocytosis due to alpha-spectrin deficiency. J Perinatol 2013;33:404-406.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.